SMS PHARMACEUTICALS Financial Statement Analysis
|
||
The Revenues of SMS PHARMACEUTICALS have decreased by -7.69% YoY .
The Earnings Per Share (EPS) of SMS PHARMACEUTICALS has decreased by Negative YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
SMS PHARMACEUTICALS Last 5 Annual Financial Results
[BOM: 532815|NSE : SMSPHARMA]
Consolidated | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
---|---|---|---|---|---|
Revenues | ₹520 Cr | ₹563 Cr | ₹412 Cr | ₹465 Cr | ₹465 Cr |
Expenses | ₹405 Cr | ₹442 Cr | ₹332 Cr | ₹375 Cr | ₹372 Cr |
Operating Profit (Excl OI) | ₹115 Cr | ₹121 Cr | ₹80 Cr | ₹90 Cr | ₹93 Cr |
Other Income | ₹5.20 Cr | ₹3.45 Cr | ₹5.11 Cr | ₹3.40 Cr | ₹2.39 Cr |
Interest | ₹19 Cr | ₹11 Cr | ₹12 Cr | ₹12 Cr | ₹15 Cr |
Depreciation | ₹32 Cr | ₹22 Cr | ₹22 Cr | ₹19 Cr | ₹20 Cr |
Profit Before Tax | ₹68 Cr | ₹91 Cr | ₹51 Cr | ₹62 Cr | ₹60 Cr |
Profit After Tax | ₹68 Cr | ₹61 Cr | ₹33 Cr | ₹41 Cr | ₹40 Cr |
Consolidated Net Profit | ₹62 Cr | ₹63 Cr | ₹32 Cr | ₹40 Cr | ₹32 Cr |
Earnings Per Share (Rs) | ₹-0.83 | ₹7.35 | ₹7.39 | ₹3.73 | ₹4.73 |
PAT Margin (%) | 0.70 | 12.25 | 10.04 | 7.25 | 8.25 |
ROE(%) | 0.83 | 15.41 | 16.07 | 9.76 | 13.67 |
ROCE(%) | 3.79 | 12.60 | 17.62 | 13.06 | 16.57 |
Total Debt/Equity(x) | 0.55 | 0.55 | 0.61 | 0.44 | 0.45 |
Key Financials |
||
Market Cap | : | ₹ 1,767.7 Cr |
Revenue (TTM) | : | ₹ 612.9 Cr |
Net Profit(TTM) | : | ₹ 41.2 Cr |
EPS (TTM) | : | ₹ 4.9 |
P/E (TTM) | : | 42.9 |
Industry Peers & Returns | 1W | 1M | 1Y |
SMS PHARMACEUTICALS | 3.4% | 30.5% | 181.2% |
SUN PHARMACEUTICAL INDUSTRIES | 3% | 2.3% | 68.2% |
CIPLA | 2.5% | 0.4% | 71.7% |
DR REDDYS LABORATORIES | -0.2% | -4.9% | 40.3% |
ZYDUS LIFESCIENCES | 5% | 10.4% | 109.1% |
DIVIS LABORATORIES | -1.6% | -7% | 23.8% |
MANKIND PHARMA | NA | NA | NA |
TORRENT PHARMACEUTICALS | 2.9% | -2.2% | 69% |
LUPIN | 2.8% | 0% | 147.8% |
SMS PHARMACEUTICALS Revenues
[BOM: 532815|NSE : SMSPHARMA]
Y-o-Y | -7.69 % |
5 Yr CAGR | 2.83 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2023 | ₹520 Cr | -7.69 | |
Mar2022 | ₹563 Cr | 36.71 | |
Mar2021 | ₹412 Cr | -11.39 | |
Mar2020 | ₹465 Cr | 0.00 | |
Mar2019 | ₹465 Cr | - |
SMS PHARMACEUTICALS Operating Profit
[BOM: 532815|NSE : SMSPHARMA]
Y-o-Y | -5.38 % |
5 Yr CAGR | 5.27 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2023 | ₹115 Cr | -5.38 | |
Mar2022 | ₹121 Cr | 51.38 | |
Mar2021 | ₹80 Cr | -11.23 | |
Mar2020 | ₹90 Cr | -3.42 | |
Mar2019 | ₹93 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | 2.51 % |
5 Yr CAGR | 2.37 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2023 | 22.05% | 2.51 | |
Mar2022 | 21.51% | 10.71 | |
Mar2021 | 19.43% | 0.21 | |
Mar2020 | 19.39% | -3.44 | |
Mar2019 | 20.08% | - |
SMS PHARMACEUTICALS Profit After Tax
[BOM: 532815|NSE : SMSPHARMA]
Y-o-Y | -0.49 % |
5 Yr CAGR | 18.32 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2023 | ₹62 Cr | -0.49 | |
Mar2022 | ₹63 Cr | 98.03 | |
Mar2021 | ₹32 Cr | -21.16 | |
Mar2020 | ₹40 Cr | 26.14 | |
Mar2019 | ₹32 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | -94.29 % |
5 Yr CAGR | -46.03 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2023 | 0.7 % | -94.29 | |
Mar2022 | 12.25 % | 22.01 | |
Mar2021 | 10.04 % | 38.48 | |
Mar2020 | 7.25 % | -12.12 | |
Mar2019 | 8.25 % | - |
SMS PHARMACEUTICALS Earnings Per Share (EPS)
[BOM: 532815|NSE : SMSPHARMA]
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | EPS | % Change | |
---|---|---|---|
Mar2023 | ₹-0.83 | Negative | |
Mar2022 | ₹7.35 | -0.54 | |
Mar2021 | ₹7.39 | 98.12 | |
Mar2020 | ₹3.73 | -21.14 | |
Mar2019 | ₹4.73 | - |
SMS PHARMACEUTICALS Return on Capital Employed (ROCE)
[BOM: 532815|NSE : SMSPHARMA]
Y-o-Y | -69.92 % |
5 Yr CAGR | -30.84 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2023 | 3.79% | -69.92 | |
Mar2022 | 12.6% | -28.49 | |
Mar2021 | 17.62% | 34.92 | |
Mar2020 | 13.06% | -21.18 | |
Mar2019 | 16.57% | - |
SMS PHARMACEUTICALS Share Price vs Sensex
Current Share Price | : | ₹208.7 |
Current MarketCap | : | ₹ 1,767.7 Cr |
Updated EOD on | : | Apr 24,2024 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SMS PHARMACEUTICALS | 3.4% |
30.5% |
181.2% |
SENSEX | 1.3% |
2.6% |
24% |
SMS PHARMACEUTICALS related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE SMALL CAP | 3.2% | 12.8% | 65.7% |
S&P BSE MIDSMALLCAP | 2.4% | 10.7% | 64.9% |
S&P BSE ALLCAP | 1.6% | 6% | 40.6% |
S&P BSE HEALTHCARE | -0.2% | 3.7% | 52.1% |
You may also like the below Video Courses
FAQ about SMS PHARMACEUTICALS Financials
How the annual revenues of SMS PHARMACEUTICALS have changed ?
The Revenues of SMS PHARMACEUTICALS have decreased by -7.69% YoY .
How the Earnings per Share (EPS) of SMS PHARMACEUTICALS have changed?
The Earnings Per Share (EPS) of SMS PHARMACEUTICALS has decreased by Negative YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs